author-photo

Christine Biaggi

17

Papers

275

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

LBA30 Single-dose carboplatin followed by involved-node radiotherapy as curative treatment for seminoma stage IIA/B: Efficacy results from the international multicenter phase II trial SAKK 01/10

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
P30.01 Extended Resections for Advanced Stages T3/T4 NSCLC After Neoadjuvant Treatment: Conclusions of SAKK Pooled Analysis (16/96, 16/00, 16/01)

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (21)
Long‐term outcome of dasatinib first‐line treatment in gastrointestinal stromal tumor: A multicenter, 2‐stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)

2018 Cancer
Show All
- Source
- Cite
- Save
Citations (18)
A phase 2 trial of ODM-201 maintenance therapy in patients with metastatic castration resistant prostate cancer (mCRPC) previously treated with a AR targeting agent and non-progressive on a second line taxane (SAKK 08/16).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Dasatinib first-line treatment in gastrointestinal stromal tumors: A multicenter phase II trial of the SAKK (SAKK 56/07).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial.

2017 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (9)
MA 15.11 CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09)

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (114)
1418PDLONG-TERM OUTCOME OF DASATINIB FIRST-LINE TREATMENT IN GASTROINTESTINAL STROMAL TUMORS: A MULTICENTER TWO STAGE PHASE II TRIAL SAKK 56/07

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)